Literature DB >> 17609503

DNA methylation is not likely to be responsible for hTERT expression in premalignant cervical lesions.

Pagona Oikonomou1, Ioannis Messinis, Aspasia Tsezou.   

Abstract

Human telomerase reverse transcriptase (hTERT) mRNA expression seems to play an important role in cervical carcinogenesis. Analysis of the hTERT promoter region revealed the presence of a CpG island and a high overall GC content, suggesting a possible role for methylation in the regulation of hTERT gene expression. The present study was designed to evaluate the role of hTERT promoter methylation and E6/E7 human papilloma virus 16 (HPV-16) mRNA expression in hTERT regulation in premalignant cervical specimens. The methylation status of the hTERT promoter gene and hTERT mRNA quantification were investigated in 26 normal and 64 specimens of abnormal cytology using the MethyLight technique, Telo-TAGGG hTERT Quantification Kit and LightCycler technology. E6/E7 HPV-16 mRNA expression was also evaluated. No significant correlations were observed between hTERT mRNA expression and hTERT promoter methylation, as well as between telomerase activity and hTERT promoter methylation in normal and in premalignant cervical specimens. E6/E7 HPV-16 mRNA expression was observed in 72% of HPV-16-infected samples and was correlated with hTERT mRNA expression and telomerase activity (P < 0.05). This is the first study investigating the role of hTERT promoter methylation in hTERT mRNA expression and telomerase activity in premalignant lesions. The observed lack of correlation suggests that other mechanisms might be involved in the regulation of hTERT expression. The correlation between hTERT mRNA and E6/E7 mRNA expression confirms the role of HPV infection in hTERT regulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609503

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  6 in total

Review 1.  Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.

Authors:  Nicolas Wentzensen; Mark E Sherman; Mark Schiffman; Sophia S Wang
Journal:  Gynecol Oncol       Date:  2008-12-02       Impact factor: 5.482

2.  Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo.

Authors:  C Weiss; O Uziel; O Wolach; J Nordenberg; E Beery; S Bulvick; G Kanfer; O Cohen; R Ram; M Bakhanashvili; H Magen-Nativ; N Shilo; M Lahav
Journal:  Br J Cancer       Date:  2012-11-20       Impact factor: 7.640

Review 3.  Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms.

Authors:  Kayla A Lewis; Trygve O Tollefsbol
Journal:  Front Genet       Date:  2016-05-09       Impact factor: 4.599

Review 4.  Telomerase Induction in HPV Infection and Oncogenesis.

Authors:  Rachel Katzenellenbogen
Journal:  Viruses       Date:  2017-07-10       Impact factor: 5.048

5.  Diagnostic Value of Methylated Human Telomerase Reverse Transcriptase in Human Cancers: A Meta-Analysis.

Authors:  Wei Gao; Yuan Shi; Wei Liu; Wei-Yin Lin; Josh Chia-Ching Wu; Jimmy Yu-Wai Chan; Thian-Sze Wong
Journal:  Front Oncol       Date:  2015-12-24       Impact factor: 6.244

Review 6.  Telomere Maintenance Mechanisms in Cancer.

Authors:  Tiago Bordeira Gaspar; Ana Sá; José Manuel Lopes; Manuel Sobrinho-Simões; Paula Soares; João Vinagre
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.